These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10763091)

  • 21. The changing epidemic of lung cancer and occupational and environmental risk factors.
    Dresler C
    Thorac Surg Clin; 2013 May; 23(2):113-22. PubMed ID: 23566963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk.
    Schabath MB; Spitz MR; Delclos GL; Gunn GB; Whitehead LW; Wu X
    Am J Ind Med; 2002 Jul; 42(1):29-37. PubMed ID: 12111688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer.
    Shen H; Spitz MR; Qiao Y; Guo Z; Wang LE; Bosken CH; Amos CI; Wei Q
    Int J Cancer; 2003 Oct; 107(1):84-8. PubMed ID: 12925960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of lung cancer from environmental exposures to tobacco smoke.
    Dockery DW; Trichopoulos D
    Cancer Causes Control; 1997 May; 8(3):333-45. PubMed ID: 9498897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of lung cancer in female passive smokers.
    Yang M; Pyo MY
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(1):75-97. PubMed ID: 16291523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lung cancer in never smoker: Epidemiology, molecular profiles and treatment].
    Hadoux J; Besse B; Planchard D
    Presse Med; 2011 Apr; 40(4 Pt 1):371-8. PubMed ID: 21420271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of Lung Cancer.
    Schwartz AG; Cote ML
    Adv Exp Med Biol; 2016; 893():21-41. PubMed ID: 26667337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of tobacco on lung cancer risk depends on CYP2D6 activity.
    Bouchardy C; Benhamou S; Dayer P
    Cancer Res; 1996 Jan; 56(2):251-3. PubMed ID: 8542575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tobacco and cancer: epidemiology and the laboratory.
    Vineis P; Caporaso N
    Environ Health Perspect; 1995 Feb; 103(2):156-60. PubMed ID: 7737063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of cancer susceptibility in humans by use of genetic polymorphisms in carcinogen metabolism.
    Ikawa S; Uematsu F; Watanabe K; Kimpara T; Osada M; Hossain A; Sagami I; Kikuchi H; Watanabe M
    Pharmacogenetics; 1995; 5 Spec No():S154-60. PubMed ID: 7581487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular epidemiology of lung cancer.
    Schwartz AG; Prysak GM; Bock CH; Cote ML
    Carcinogenesis; 2007 Mar; 28(3):507-18. PubMed ID: 17183062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypes of lung cancer and statistical interactions between tobacco smoking and occupational exposure to asbestos and crystalline silica from a large case-only study: The CaProMat study.
    El Zoghbi M; Salameh P; Stücker I; Paris C; Pairon JC; Gislard A; Siemiatycki J; Bonneterre V; Clin B; Brochard P; Delva F; Lacourt A
    Lung Cancer; 2017 Oct; 112():140-155. PubMed ID: 29191587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genetics of tobacco-induced malignancy.
    Davidson BJ; Hsu TC; Schantz SP
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1198-205. PubMed ID: 8217079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of lung cancer: smoking, secondhand smoke, and genetics.
    Steliga MA; Dresler CM
    Surg Oncol Clin N Am; 2011 Oct; 20(4):605-18. PubMed ID: 21986260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humans.
    Bartsch H; Rojas M; Alexandrov K; Camus AM; Castegnaro M; Malaveille C; Anttila S; Hirvonen K; Husgafvel-Pursiainen K; Hietanen E
    Pharmacogenetics; 1995; 5 Spec No():S84-90. PubMed ID: 7581496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular epidemiology of oxidative damage to DNA and cancer.
    Caporaso N
    J Natl Cancer Inst; 2003 Sep; 95(17):1263-5. PubMed ID: 12953074
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Alberg AJ; Brock MV; Ford JG; Samet JM; Spivack SD
    Chest; 2013 May; 143(5 Suppl):e1S-e29S. PubMed ID: 23649439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 and ras gene mutations in lung cancer: implications for smoking and occupational exposures.
    Husgafvel-Pursiainen K; Ridanpää M; Anttila S; Vainio H
    J Occup Environ Med; 1995 Jan; 37(1):69-76. PubMed ID: 7620945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer in never smokers--a different disease.
    Sun S; Schiller JH; Gazdar AF
    Nat Rev Cancer; 2007 Oct; 7(10):778-90. PubMed ID: 17882278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression.
    Williams JA
    Carcinogenesis; 2001 Feb; 22(2):209-14. PubMed ID: 11181440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.